Literature DB >> 16410558

Cerebral palsy and perinatal exposure to neurotropic viruses.

Eva Alberman, Catherine Peckham.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16410558      PMCID: PMC1326917          DOI: 10.1136/bmj.332.7533.63

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  Overview: infection during pregnancy and neurologic outcome in the child.

Authors:  Karin B Nelson; Rodney E Willoughby
Journal:  Ment Retard Dev Disabil Res Rev       Date:  2002

2.  Neurotropic viruses and cerebral palsy: population based case-control study.

Authors:  Catherine S Gibson; Alastair H MacLennan; Paul N Goldwater; Eric A Haan; Kevin Priest; Gustaaf A Dekker
Journal:  BMJ       Date:  2006-01-06

3.  Cerebral palsy epidemiology: where are we now and where are we going?

Authors:  L Mutch; E Alberman; B Hagberg; K Kodama; M V Perat
Journal:  Dev Med Child Neurol       Date:  1992-06       Impact factor: 5.449

4.  Congenital cytomegalovirus infection: predisposing maternal factors.

Authors:  P M Preece; P Tookey; A Ades; C S Peckham
Journal:  J Epidemiol Community Health       Date:  1986-09       Impact factor: 3.710

5.  Congenital and maternal cytomegalovirus infections in a London population.

Authors:  P D Griffiths; C Baboonian; D Rutter; C Peckham
Journal:  Br J Obstet Gynaecol       Date:  1991-02

Review 6.  Herpesviridae infections in newborns: varicella zoster virus, herpes simplex virus, and cytomegalovirus.

Authors:  Andrea M Enright; Charles G Prober
Journal:  Pediatr Clin North Am       Date:  2004-08       Impact factor: 3.278

7.  Infectious and inflammatory mechanisms in preterm birth and cerebral palsy.

Authors:  Bo Jacobsson
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2004-08-10       Impact factor: 2.435

  7 in total
  1 in total

1.  Knowledge of congenital cytomegalovirus (cCMV) among physical and occupational therapists in the United States.

Authors:  Kathleen M Muldoon; Amy Armstrong-Heimsoth; Jodi Thomas
Journal:  PLoS One       Date:  2017-10-04       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.